French pharma group Ipsen closes in on its next drug deals

Under Meek, an American who took over as CEO in July 2016, the 89-year-old French drug company has become more international, with a sharply increased focus on the United States, the world’s biggest and most profitable drugs market.

Original source:

Related Posts